Health Trials

ROS1-positive Non-Small Cell Lung Cancer (NSCLC)

1

Review clinical trials related to ROS1-positive Non-Small Cell Lung Cancer (NSCLC). Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Available

Expanded Access Program of Zidesamtinib (NVL-520) for Patients With Advanced ROS1+ NSCLC or Other ROS1+ Solid Tumors

The Expanded Access Program will provide an alternate mechanism for these patients, who lack satisfactory therapeutic alternatives and cannot participate in a zidesamtinib clinical trial, to access investigational zidesamtinib.

Trial details
Age: 18+Biological sex: AllType: Expanded AccessSponsor: Nuvalent Inc.Updated: Jun 15, 2026Locations: 37
Eligibility criteria

Age ≥18 years. [+4]

Prior receipt of zidesamtinib. [+3]

Read more